MorphoSys Gets $1.4M to Develop Cancer Program, Explore Biomarkers
July 06, 2010
MorphoSys Gets $1.4M to Develop Cancer Program, Explore Biomarkers
As part of the effort, MorphoSys will explore relevant biomarkers for the anti-CD38 approach in collaboration with the university hospital of Munich Technical University.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.